Works matching DE "ROSIGLITAZONE"

Results: 699

Protective effect of rosiglitazone, quercetin, and their combination on fructose-induced metabolic syndrome in rats.

Published in:

Indian Journal of Pharmacology, 2015, v. 47, n. 6, p. 620, doi. 10.4103/0253-7613.169577

By:

Abo-youssef, Amira M.

Publication type:

Article

Protective effect of rosiglitazone, quercetin, and their combination on fructose-induced metabolic syndrome in rats.

Published in:

Indian Journal of Pharmacology, 2015, v. 47, n. 6, p. 620, doi. 10.4103/0253-7613.169577

By:

Abo-youssef, Amira M.

Publication type:

Article

Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: Possible role of tissue inhibitor of metalloproteinase-3.

Published in:

Indian Journal of Pharmacology, 2015, v. 47, n. 2, p. 153, doi. 10.4103/0253-7613.153421

By:

Nagar, Jignesh K.;
Patel, Praful P.;
Mohapatra, Jogeswar N.;
Sharma, Manoranjan M.;
Pandya, Gaurav M.;
Umar, Malik M.;
Chatterjee, Abhijit A.;
Deshpande, Shrikalp S.;
Jain, Mukul R.;
Soni, Hitesh M.

Publication type:

Article

Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1193, doi. 10.1007/s00280-010-1535-2

By:

Tapia-Pérez, Jorge;
Kirches, Elmar;
Mawrin, Christian;
Firsching, Raimund;
Schneider, Thomas

Publication type:

Article

Cancer and bone fractures in observational follow-up of the RECORD study.

Published in:

Acta Diabetologica, 2015, v. 52, n. 3, p. 539, doi. 10.1007/s00592-014-0691-y

By:

Jones, Nigel;
Curtis, Paula;
Home, Philip

Publication type:

Article

Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials.

Published in:

Acta Diabetologica, 2014, v. 51, n. 1, p. 91, doi. 10.1007/s00592-013-0504-8

By:

Monami, Matteo;
Dicembrini, Ilaria;
Mannucci, Edoardo

Publication type:

Article

Thiazolidinediones protect mouse pancreatic β-cells directly from cytokine-induced cytotoxicity through PPARγ-dependent mechanisms.

Published in:

Acta Diabetologica, 2013, v. 50, n. 2, p. 163, doi. 10.1007/s00592-010-0239-8

By:

Wang, An-ping;
Li, Xia;
Zheng, Ying;
Liu, Bi-lian;
Huang, Gan;
Yan, Xiang;
Liu, Zhenqi;
Zhou, Zhiguang

Publication type:

Article

Rosiglitazone decreases fasting plasma peptide YY in type 2 diabetic women: a possible role in weight gain?

Published in:

Acta Diabetologica, 2012, v. 49, p. 115, doi. 10.1007/s00592-011-0352-3

By:

Berberoglu, Zehra;
Yazici, Ayse;
Bayraktar, Nilufer;
Demirag, Nilgun

Publication type:

Article

The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.

Published in:

Acta Diabetologica, 2011, v. 48, n. 4, p. 297, doi. 10.1007/s00592-011-0276-y

By:

Fidan, Evren;
Onder Ersoz, H.;
Yilmaz, Mustafa;
Yilmaz, Hulya;
Kocak, Mustafa;
Karahan, Caner;
Erem, Cihangir

Publication type:

Article

In-vivo antioxidant and anti-inflammatory activity of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ( PPAR-γ) agonists in animal model of bronchial asthma.

Published in:

Journal of Pharmacy & Pharmacology, 2015, v. 67, n. 10, p. 1421, doi. 10.1111/jphp.12445

By:

El‐Naa, Mona M.;
El‐Refaei, Mohamed F.;
Nasif, Wesam A.;
Abduljawad, Suha H.;
El‐Brairy, Amany I.;
El‐Readi, Mahmoud Z.

Publication type:

Article

Induction of peroxisomal proliferator-activated receptor γ and peroxisomal proliferator-activated receptor γ coactivator 1 by unsaturated fatty acids, retinoic acid, and carotenoids in preadipocytes obtained from bovine white adipose tissue<sup>1,2</sup>

Published in:

Journal of Animal Science, 2010, v. 88, n. 5, p. 1801, doi. 10.2527/jas.2009-2579

By:

Garcia-Rojas, P.;
Antaramian, A.;
González-Dávalos, L.;
Villarroya, F.;
Shimada, A.;
Varela-EchavarrIa, A.;
Moral, 0.

Publication type:

Article

The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.

Published in:

Acta Neuropathologica Communications, 2016, v. 4, p. 1, doi. 10.1186/s40478-016-0346-z

By:

Normando, Eduardo Maria;
Davis, Benjamin Michael;
De Groef, Lies;
Nizari, Shereen;
Turner, Lisa A.;
Ravindran, Nivedita;
Pahlitzsch, Milena;
Brenton, Jonathan;
Malaguarnera, Giulia;
Li Guo;
Somavarapu, Satyanarayana;
Cordeiro, Maria Francesca

Publication type:

Article

Expression of Concern on “The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone”.

Published in:: Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/2938413
Publication type:: Article

Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats.

Published in:

Journal of Diabetes Research, 2018, p. 1, doi. 10.1155/2018/4627842

By:

Li, Jia;
Xue, Yao-Ming;
Zhu, Bo;
Pan, Yong-Hua;
Zhang, Yan;
Wang, Chunxia;
Li, Yuhao

Publication type:

Article

Calculated effect of fluid retention upon velocity of blood flow and turbulence: Implications for atherosclerosis.

Published in:

Clinical Hemorheology & Microcirculation, 2011, v. 47, n. 2, p. 79, doi. 10.3233/CH-2010-1369

By:

Blankfield, Robert P.

Publication type:

Article

The impact of rosiglitazone on nitric oxide bioavailability and endothelial function.

Published in:

Clinical Hemorheology & Microcirculation, 2010, v. 45, n. 2-4, p. 325, doi. 10.3233/CH-2010-1315

By:

Perampaladas, Kumar;
Parker, John D.;
Gori, Tommaso

Publication type:

Article

Chlorogenic Acid Functions as a Novel Agonist of PPARγ2 during the Differentiation of Mouse 3T3-L1 Preadipocytes.

Published in:

BioMed Research International, 2018, p. 1, doi. 10.1155/2018/8594767

By:

Peng, Shu-guang;
Pang, Yi-lin;
Zhu, Qi;
Kang, Jing-he;
Liu, Ming-xin;
Wang, Zheng

Publication type:

Article

Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF.

Published in:

Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 945, doi. 10.20892/j.issn.2095-3941.2022.0299

By:

Hongquan Wang;
Shuang Wu;
Yan Wang;
Bo Tang

Publication type:

Article

Healthcare and associated costs related to type 2 diabetes in youth and adolescence: the TODAY clinical trial experience.

Published in:

Pediatric Diabetes, 2019, v. 20, n. 6, p. 702, doi. 10.1111/pedi.12869

By:

Songer, Thomas J.;
Haymond, Morey W.;
Glazner, Judith E.;
Klingensmith, Georgeanna J.;
Laffel, Lori M.;
Zhang, Ping;
Hirst, Kathryn

Publication type:

Article

Determination of Pka Values of Antidiabetic Drugs from Mobility Data and Pharmaceutical Analysis by Capillary Electrophoresis.

Published in:

Journal of the Chemical Society of Pakistan, 2022, v. 44, n. 4, p. 366, doi. 10.52568/001068/jcsp/44.04.2022

By:

Sanli, Senem;
Sardogan, Seyfi;
Özdemir, Ayse;
Atalay, Baris

Publication type:

Article

High Concentrations of Rosiglitazone Reduce mRNA and Protein Levels of LRP1 in HepG2 Cells.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00772

By:

Rondón-Ortiz, Alejandro N.;
Lino Cardenas, Christian L.;
Martínez-Málaga, Jimena;
Gonzales-Urday, Ana L.;
Gugnani, Kuljeet S.;
Böhlke, Mark;
Maher, Timothy J.;
Pino-Figueroa, Alejandro J.

Publication type:

Article

Rosiglitazone May Assist With Glycemic Control in the ICU.

Published in:

Journal of Intensive Care Medicine, 2010, v. 25, n. 2, p. 117, doi. 10.1177/0885066609355264

By:

Lissauer, Matthew;
Feild, Carinda;
Fasanmi, Foyin;
Johnson, Steven B.

Publication type:

Article

Beneficial Effects of Aerobic Exercise Training Combined with Rosiglitazone on Glucose Metabolism in Otsuka Long Evans Tokushima Fatty Rats.

Published in:

Diabetes & Metabolism Journal, 2017, v. 41, n. 6, p. 474, doi. 10.4093/dmj.2017.41.6.474

By:

Shan-Ji Piao;
So Hun Kim;
Young Ju Suh;
Seong-Bin Hong;
Seong Hee Ahn;
Da Hae Seo;
In-Sun Park;
Moonsuk Nam

Publication type:

Article

Synthetic optimization of rosiglitazone and related intermediates for industrial purposes.

Published in:

Research on Chemical Intermediates, 2016, v. 42, n. 3, p. 2023, doi. 10.1007/s11164-015-2132-0

By:

Meng, Ge;
Zheng, Meilin;
Dong, Mengshu;
Gao, Yang;
Zheng, Aqun;
Li, Zhenyu;
Hu, Ruizhi

Publication type:

Article

Results of Rosiglitazone Therapy in Patients with Thyroglobulin-Positive and Radioiodine-Negative Advanced Differentiated Thyroid Cancer.

Published in:

Thyroid, 2009, v. 19, n. 9, p. 953, doi. 10.1089/thy.2008.0371

By:

Electron Kebebew;
Sheila Lindsay;
Orlo H. Clark;
Kenneth A. Woeber;
Randall Hawkins;
Francis S. Greenspan

Publication type:

Article

Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis.

Published in:

Journal of Diabetes Investigation, 2015, v. 6, n. 1, p. 78, doi. 10.1111/jdi.12246

By:

Lu, Yu;
Ma, Delin;
Xu, Weijie;
Shao, Shiying;
Yu, Xuefeng

Publication type:

Article

Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan.

Published in:

Cancers, 2023, v. 15, n. 17, p. 4276, doi. 10.3390/cancers15174276

By:

Tseng, Chin-Hsiao

Publication type:

Article

Peroxisome proliferator-activated receptor gamma (PPARγ) regulates thrombospondin-1 and Nox4 expression in hypoxia-induced human pulmonary artery smooth muscle cell proliferation.

Published in:

Pulmonary Circulation, 2012, v. 2, n. 4, p. 483, doi. 10.4103/2045-8932.105037

By:

Green, David E.;
Bum-Yong Kang;
Murphy, Tamara C.;
Hart, C. Michael

Publication type:

Article

Rosiglitazone induces hepatocyte injury by increasing DCA accumulation through OATP1A4 inhibiting in mice.

Published in:

Arabian Journal of Chemistry, 2023, v. 16, n. 10, p. N.PAG, doi. 10.1016/j.arabjc.2023.105142

By:

Tan, Daopeng;
Ling, Lei;
Qin, Lin;
Lu, Yanliu;
Wu, Di;
He, Yuqi

Publication type:

Article

Simultaneous determination of Nitazoxanide and Ofloxacin in pharmaceutical preparations using UV-spectrophotometric and high performance thin layer chromatography methods.

Published in:

Arabian Journal of Chemistry, 2017, v. 10, p. S62, doi. 10.1016/j.arabjc.2012.07.009

By:

Sharma, Smita;
Sharma, Mukesh C.;
Sahu, Nitendra K.

Publication type:

Article

Electrochemical determination of rosiglitazone by square-wave adsorptive stripping voltammetry method

Published in:

Arabian Journal of Chemistry, 2012, v. 5, n. 3, p. 383, doi. 10.1016/j.arabjc.2011.07.011

By:

Al-Ghamdi, Ali F.;
Hefnawy, Mohamed M.

Publication type:

Article

DISCUSSION.

Published in:: Ocular Surgery News, 2012, p. 17
Publication type:: Article

Efecto lipolítico del Resveratrol en células 3T3-L1.

Published in:

Salud Uninorte, 2008, v. 24, n. 2, p. 165

By:

Celis, Luis Gustavo;
Rozo, Catalina;
Garay, Jennifer;
Vargas, Diana;
Lizcano, Fernando

Publication type:

Article

Rosiglitazone alleviates LPS-induced endometritis via suppression of TLR4-mediated NF-κB activation.

Published in:

PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0280372

By:

Bao, Hongchu;
Cong, Jianxiang;
Qu, Qinglan;
He, Shunzhi;
Zhao, Dongmei;
Zhao, Huishan;
Yin, Shuyuan;
Ma, Ding

Publication type:

Article

Antidiabetic drug administration prevents bone mineral density loss: Evidence from a two-sample Mendelian randomization study.

Published in:

PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0300009

By:

Chen, Mingzhu;
Lin, Shuisen;
Chen, Wanqiong;
Chen, Xiaoqiang

Publication type:

Article

Effect of Rosiglitazone, the Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, on Apoptosis, Inflammatory Cytokines and Oxidative Stress in pentylenetetrazole-Induced Seizures in Kindled Mice.

Published in:

Neurochemical Research, 2023, v. 48, n. 9, p. 2870, doi. 10.1007/s11064-023-03951-7

By:

Li, Jinliang;
Chen, Suping;
Wang, Feilong;
Zhang, Jingyu;
Zeyghami, Mohammad Ali;
Koohsar, Faramarz;
Ayatollahi, Ali Asghar;
Amini, Abolfazl

Publication type:

Article

Rosiglitazone Suppresses Glioma Cell Growth and Cell Cycle by Blocking the Transforming Growth Factor-Beta Mediated Pathway.

Published in:

Neurochemical Research, 2012, v. 37, n. 10, p. 2076, doi. 10.1007/s11064-012-0828-8

By:

Wang, Peng;
Yu, Jinpu;
Yin, Qiang;
Li, Wenliang;
Ren, Xiubao;
Hao, Xishan

Publication type:

Article

Meta-Analysis of Clinical Trials With Sparse Binary Outcomes Using Zero-Inflated Binomial (ZIB) Models.

Published in:

Statistics in Biopharmaceutical Research, 2019, v. 11, n. 3, p. 228, doi. 10.1080/19466315.2018.1537885

By:

Dong, Cheng;
Zhao, Yueqin;
Tiwari, Ram

Publication type:

Article

Sclerostin‐Neutralizing Antibody Treatment Rescues Negative Effects of Rosiglitazone on Mouse Bone Parameters.

Published in:

Journal of Bone & Mineral Research, 2021, v. 36, n. 1, p. 158, doi. 10.1002/jbmr.4170

By:

Farrell, Mariah;
Fairfield, Heather;
Costa, Samantha;
D'Amico, Anastasia;
Falank, Carolyne;
Brooks, Daniel J;
Reagan, Michaela R

Publication type:

Article

Development and Validation of a RP- HPLC Method for Simultaneous Estimation of Rosiglitazone and Metformin in Bulk and Tablet Dosage Form.

Published in:

Eurasian Journal of Analytical Chemistry, 2011, v. 6, n. 3, p. 189

By:

Mittan, Dhirender Singh;
Dwivedi, Suresh C.;
Kushnoor, Ashok

Publication type:

Article

The Impact of Chronic Kidney Disease and Short-Term Treatment with Rosiglitazone on Plasma Cell-Free DNA Levels.

Published in:

PPAR Research, 2014, p. 1, doi. 10.1155/2014/643189

By:

McGuire, Amanda L.;
Urosevic, Nadia;
Chan, Doris T.;
Dogra, Gursharan;
Inglis, Timothy J. J.;
Chakera, Aron

Publication type:

Article

Rosiglitazone Attenuated Endothelin-1-Induced Vasoconstriction of Pulmonary Arteries in the Rat Model of Pulmonary Arterial Hypertension via Differential Regulation of ET-1 Receptors.

Published in:

PPAR Research, 2014, p. 1, doi. 10.1155/2014/374075

By:

Yahan Liu;
Xiao Yu Tian;
Yu Huang;
Nanping Wang

Publication type:

Article

PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice.

Published in:

PPAR Research, 2013, p. 1, doi. 10.1155/2013/612971

By:

Ying Sun;
Zhanjun Jia;
Gang Liu;
Li Zhou;
Mi Liu;
Baoxue Yang;
Tianxin Yang

Publication type:

Article

PPARγ Ligands Regulate Noncontractile and Contractile Functions of Airway Smooth Muscle: Implications for Asthma Therapy.

Published in:

PPAR Research, 2012, p. 1, doi. 10.1155/2012/809164

By:

Donovan, Chantal;
Xiahui Tan;
Bourke, Jane Elizabeth

Publication type:

Article

Prenatal Rosiglitazone Administration to Neonatal Rat Pups Does Not Alter the Adult Metabolic Phenotype.

Published in:

PPAR Research, 2012, p. 1, doi. 10.1155/2012/604216

By:

Sierra, Hernan;
Sakurai, Reiko;
Lee, W. N. Paul;
Truong, Nghia C.;
Torday, John S.;
Rehan, Virender K.

Publication type:

Article

In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist.

Published in:

PPAR Research, 2012, p. 1, doi. 10.1155/2012/546548

By:

He, B. K.;
Ning, Z. Q.;
Li, Z. B.;
Shan, S.;
Pan, D. S.;
Ko, B. C. B.;
Li, P. P.;
Shen, Z. F.;
Dou, G. F.;
Zhang, B. L.;
Lu, X. P.;
Gao, Y.

Publication type:

Article

The Effect of PPAR Agonists on the Migration of Mature and Immature Eosinophils.

Published in:

PPAR Research, 2012, p. 1, doi. 10.1155/2012/235231

By:

Smith, Steven G.;
Imaoka, Haruki;
Punia, Neha;
Irshad, Anam;
Janssen, Luke L.;
Sehmi, Roma;
Gauvreau, Gail M.

Publication type:

Article

Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS.

Published in:

PPAR Research, 2011, p. 1, doi. 10.1155/2011/291656

By:

Zhigang Zhao;
Zhidan Luo;
Peijian Wang;
Jing Sun;
Hao Yu;
Tingbing Cao;
Yinxing Ni;
Jing Chen;
Zhencheng Yan;
Daoyan Liu;
Zhiming Zhu

Publication type:

Article

Is There a Biological Basis for Treatment of Fibrodysplasia Ossificans Progressiva with Rosiglitazone? Potential Benefits and Undesired Effects.

Published in:

PPAR Research, 2010, p. 1, doi. 10.1155/2010/541927

By:

Bocciardi, Renata;
Ravazzolo, Roberto

Publication type:

Article

Coordinate Transcriptomic and Metabolomic Effects of the Insulin Sensitizer Rosiglitazone on Fundamental Metabolic Pathways in Liver, Soleus Muscle, and Adipose Tissue in Diabetic db/db Mice.

Published in:

PPAR Research, 2010, p. 1, doi. 10.1155/2010/679184

By:

Le Bouter, Sabrina;
Rodriguez, Marianne;
Guigal-Stephan, Nolwen;
Courtade-Gaïani, Sophie;
Xuereb, Laura;
de Montrion, Catherine;
Croixmarie, Vincent;
Umbdenstock, Thierry;
Boursier-Neyret, Claire;
Lonchampt, Michel;
Brun, Manuel;
Dacquet, Catherine;
Ktorza, Alain;
Lockhart, Brian-Paul;
Galizzi, Jean-Pierre

Publication type:

Article